Here's Why You Should Retain Ensign Group (ENSG) Stock Now

Zacks07-03 01:18

The Ensign Group, Inc. ENSG is benefiting from improved service revenues, a series of acquisitions and a strong financial position. An optimistic 2024 business outlook also reinforces investors’ ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2448419389?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/cJ7Tfg7ljIEMGiDFsviYYw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/afe95824683969079aeba27c8210bd37","is_english":true,"pubTime":"2024-07-03 01:18","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2448419389","market":"us","top_or_hot":-1,"title":"Here's Why You Should Retain Ensign Group (ENSG) Stock Now","media":"Zacks","content":"<div>\n<p>The Ensign Group, Inc. ENSG is benefiting from improved service revenues, a series of acquisitions and a strong financial position. An optimistic 2024 business outlook also reinforces investors’ ...</p>\n\n<a href=\"https://finance.yahoo.com/news/heres-why-retain-ensign-group-171800742.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here's Why You Should Retain Ensign Group (ENSG) Stock Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere's Why You Should Retain Ensign Group (ENSG) Stock Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-07-03 01:18 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/heres-why-retain-ensign-group-171800742.html><strong>Zacks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Ensign Group, Inc. ENSG is benefiting from improved service revenues, a series of acquisitions and a strong financial position. An optimistic 2024 business outlook also reinforces investors’ ...</p>\n\n<a href=\"https://finance.yahoo.com/news/heres-why-retain-ensign-group-171800742.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0211327993.USD","symbol_name":"TEMPLETON GLOBAL EQUITY INCOME \"A\" (USD) ACC","start_time":0,"source_url":"https://finance.yahoo.com/news/heres-why-retain-ensign-group-171800742.html","article_id":"2448419389","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/cJ7Tfg7ljIEMGiDFsviYYw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/afe95824683969079aeba27c8210bd37"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2448419389","pubTimestamp":1719940680,"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"The Ensign Group, Inc. ENSG is benefiting from improved service revenues, a series of acquisitions and a strong financial position. An optimistic 2024 business outlook also reinforces investors’ confidence in the stock.Ensign Group carries a Zacks Rank #3  at present.The stock has gained 32.2% in the past year compared with the industry’s 36.1% growth. The Medical sector and the S&P 500 composite index have increased 6% and 23.7%, respectively, in the same time frame.Ensign Group’s inorganic growth strategy is impressive. The company is actively acquiring facilities in various U.S. regions, which allows it to collaborate with local caregiver teams. This approach provides ENSG with a deep understanding of regional needs and enables it to deliver high-qual","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0211327993.USD":"TEMPLETON GLOBAL EQUITY INCOME \"A\" (USD) ACC","LU1201861165.SGD":"Natixis Harris Associates Global Equity PA SGD","LU0708994859.HKD":"TEMPLETON GLOBAL \"A\" (HKD) ACC","LU0690374615.EUR":"FUNDSMITH EQUITY \"R\" (EUR) ACC","LU0878866978.SGD":"First Eagle Amundi International AHS-QD SGD-H","LU2362541513.USD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (USD) ACC","LU2468319806.SGD":"MANULIFE GF HEALTHCARE \"AA\" (SGDHDG) ACC","LU0211328371.USD":"TEMPLETON GLOBAL EQUITY INCOME \"A\" (MDIS) (USD)   INC","LU0433182093.SGD":"First Eagle Amundi International AS-C SGD","BK4185":"保健护理机构","SG9999014021.USD":"UNITED GLOBAL DURABLE EQUITIES (USDHDG) ACC","IE00B775SV38.USD":"NEUBERGER BERMAN US MULTICAP OPPORTUNITIES \"A\" (USD) ACC","LU0528227936.USD":"富达环球人口趋势基金A-ACC","LU0114720955.EUR":"SUSTAINABLE GLOBAL HEALTH CARE \"A\" INC","IE00B3S45H60.SGD":"Neuberger Berman US Multicap Opportunities A Acc SGD-H","LU0128525929.USD":"TEMPLETON GLOBAL \"A\" (USD) ACC","LU0130103400.USD":"Natixis Harris Associates Global Equity RA USD","LU0068578508.USD":"First Eagle Amundi International Cl AU-C USD","LU1791710582.SGD":"Fidelity Global Demographics A-ACC-SGD (SGD/USD hedged)","LU1791710400.SGD":"Fidelity Global Demographics A-ACC-SGD","THC":"泰尼特","GB00B4QBRK32.GBP":"FUNDSMITH EQUITY \"R\" (GBP) INC","BK4585":"ETF&股票定投概念","GB00B4LPDJ14.GBP":"FUNDSMITH EQUITY \"R\" (GBP) ACC","LU0690374961.EUR":"FUNDSMITH EQUITY \"R\" (EUR) INC","LU0310800379.SGD":"FTIF - Templeton Global A Acc SGD","HCA":"HCA控股","SG9999014039.USD":"UNITED GLOBAL DURABLE EQUITIES (USDHDG) INC","LU1261432733.SGD":"Fidelity World A-ACC-SGD","SG9999014005.SGD":"United Global Durable Equities Fund Acc SGD","LU2362541273.HKD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (HKD) ACC","SG9999014013.SGD":"United Global Durable Equities Fund Dis SGD","BK4566":"资本集团","BK4082":"医疗保健设备","SYK":"史赛克","LU1489326972.SGD":"First Eagle Amundi International AHS-MD SGD-H","BK4588":"碎股","LU0648000940.SGD":"Natixis Harris Associates Global Equity RA SGD","LU0130102774.USD":"Natixis Harris Associates US Equity RA USD","LU1267930573.SGD":"TEMPLETON GLOBAL \"AA\" (SGD) ACC A","LU0882574055.USD":"富达全球健康医疗A ACC","LU1267930490.SGD":"TEMPLETON GLOBAL EQUITY INCOME \"AS\" (SGD) INC A","LU2362540622.SGD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (SGDHDG) ACC","ENSG":"恩赛因","LU2404859741.USD":"FUNDSMITH EQUITY FUND \"R\" (USD) INC","LU0648001328.SGD":"Natixis Harris Associates US Equity RA SGD","LU0868494617.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD) ACC","LU2404859667.USD":"FUNDSMITH EQUITY FUND \"R\" (USD) ACC","LU0985489474.SGD":"First Eagle Amundi International AHS-C SGD-H"},"translate_title":"这就是为什么您现在应该保留Ensign Group(ENSG)股票","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"THC":1,"SYK":1,"ENSG":1,"HCA":0.9},"content_text":"The Ensign Group, Inc. ENSG is benefiting from improved service revenues, a series of acquisitions and a strong financial position. An optimistic 2024 business outlook also reinforces investors’ confidence in the stock.  \nZacks Rank & Price Performance\nEnsign Group carries a Zacks Rank #3 (Hold) at present.\nThe stock has gained 32.2% in the past year compared with the industry’s 36.1% growth. The Medical sector and the S&P 500 composite index have increased 6% and 23.7%, respectively, in the same time frame.\nImage Source: Zacks Investment Research\nRobust Growth Prospects\nThe Zacks Consensus Estimate for Ensign Group’s 2024 earnings is pegged at $4.95 per share, indicating an improvement of 12.6% from the year-earlier reading, while the same for revenues stands at $4.1 billion, implying an 11% increase from the prior-year actual.The consensus mark for 2025 earnings is pegged at $5.46 per share, indicating 10.2% growth from the 2024 estimate. The same for revenues is $4.5 billion, which indicates a rise of 9.4% from the 2024 estimate.\nDecent Surprise History\nENSG’s earnings outpaced estimates in two of the trailing four quarters and matched the mark twice, the average surprise being 0.95%.\nSolid Return on Equity\nEnsign Group’s efficiency in utilizing shareholders’ funds can be substantiated by its return on equity of 19.1% as of Mar 31, 2024, against the industry’s negative return of 13.8%. \nA Favorable 2024 Outlook\nENSG anticipates revenues within the range of $4.13-$4.17 billion in 2024, the midpoint of which indicates 11.3% growth from the 2023 reported figure.\nAdjusted earnings per share are estimated to be between $5.29 and $5.47 this year. The midpoint of the outlook indicates 13% growth from the 2023 reported figure.\nKey Business Tailwinds\nEnsign Group’s revenue growth is primarily driven by increasing service revenues from its enhanced healthcare services provided at skilled nursing, rehabilitation and senior living facilities. An aging U.S. population is expected to sustain the strong demand for ENSG’s senior living services while the significant need for effective rehabilitation services, which help individuals return to daily activities, is anticipated to boost its Skilled Services segment’s revenues.\nThe strong performance of ENSG’s Skilled Services and Standard Bearer segments also contributes to revenue growth. Through the Standard Bearer unit, the company earns rental revenues from leasing post-acute care properties, which it has purchased, to healthcare operators under triple-net lease arrangements. These agreements are advantageous for ENSG as the company not only receives rental income but also passes the property-related costs to the tenants.\nEnsign Group’s inorganic growth strategy is impressive. The company is actively acquiring facilities in various U.S. regions, which allows it to collaborate with local caregiver teams. This approach provides ENSG with a deep understanding of regional needs and enables it to deliver high-quality healthcare services to underserved communities.\nIn June 2024, Ensign Group purchased the real estate and operations of an Arizona-based 32-bed skilled nursing facility, Wellsprings of Gilbert. Concurrently, it also acquired the operations of a skilled nursing facility in Colorado, The Springs at St. Andrews Village.\nSuch proactive growth initiatives expand Ensign Group’s healthcare portfolio and national presence. The company currently operates 312 healthcare facilities across several U.S. states and owns 120 real estate assets. Acquisitions remain a top priority for management when deploying capital.\nTo support such continuous business investments, maintaining a solid financial position is essential. Ensign Group boasts strong cash reserves and sufficient cash-generating capabilities. These financial strengths also enable ENSG to reward shareholders through share buybacks and dividend payments. The company has resorted to dividend hikes for straight 21 years.\nStocks to Consider\nSome better-ranked stocks in the Medical space are Tenet Healthcare Corporation THC, HCA Healthcare, Inc. HCA and Stryker Corporation SYK. While Tenet Healthcare sports a Zacks Rank #1 (Strong Buy), HCA Healthcare and Stryker carry a Zacks Rank #2 (Buy) each at present. You can see the complete list of today’s Zacks #1 Rank stocks here.\nTenet Healthcare’s earnings surpassed estimates in each of the last four quarters, the average surprise being 56.50%. The Zacks Consensus Estimate for THC’s 2024 earnings indicates a 22.5% rise from the prior-year tally. The consensus mark for THC’s earnings has moved 35.7% north in the past 60 days.The bottom line of HCA Healthcare outpaced estimates in three of the trailing four quarters and missed the mark once, the average surprise being 5.64%. The Zacks Consensus Estimate for HCA’s 2024 earnings indicates a 10% rise while the same for revenues implies an improvement of 7.2% from the respective prior-year figures. The consensus mark for HCA’s earnings has moved 0.5% north in the past 60 days.Stryker’s earnings outpaced estimates in each of the trailing four quarters, the average surprise being 4.93%. The Zacks Consensus Estimate for SYK’s 2024 earnings indicates a 12.7% rise, while the same for revenues implies an improvement of 8.9% from the respective prior-year tallies. The consensus mark for SYK’s earnings has moved up 0.8% in the past 60 days.Shares of Tenet Healthcare, HCA Healthcare and Stryker have gained 64.8%, 6.8% and 12%, respectively, in the past year.\nWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report\nStryker Corporation (SYK) : Free Stock Analysis Report\nTenet Healthcare Corporation (THC) : Free Stock Analysis Report\nHCA Healthcare, Inc. (HCA) : Free Stock Analysis Report\nThe Ensign Group, Inc. (ENSG) : Free Stock Analysis Report\nTo read this article on Zacks.com click here.\nZacks Investment Research","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2448419389"}